Is prolonged survival possible for patients with supraclavicular node metastases in non-small cell lung cancer treated with chemoradiotherapy?: Analysis of the radiation therapy oncology group experience

International Journal of Radiation Oncology Biology Physics

Volumn 44, Issue 4, 1999, Pages 847-853

  Machtay, M ^a   Seiferheld, W ^b   Komaki, R ^c   Cox, J D ^c   Sause, W T ^d   Byhardt, R W ^e  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b RTOG Headquarters   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d LDS HOSPITAL   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

CARCINOMA, NON-SMALL-CELL LUNG; CLAVICLE; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 0033013517     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00120-0     Document Type: Article

References (17)

1. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J. 311:1995;899-909.
2. American Joint Committee on Cancer (AJCC) cancer staging manual. 1988;Lippincott-Raven, Philadelphia.
3. American Joint Committee on Cancer (AJCC) cancer staging manual. 1997;Lippincott-Raven, Philadelphia.
4. Dillman R.O., Seagren S.L., Propert K.J., et al. A randomized trial of induction chemotherapy plus high-dose radiation vs. radiation alone in stage III non-small cell lung cancer. N Engl J Med. 323:1990;940-945.
5. Byhardt R.W. The evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys. 32:1995;1513-1525.
6. Sause W.T., Scott C., Taylor S., Byhardt R.W., Banker F.L., Thomson H.W., Jones T.K., Cooper J.S., Lindberg R. Phase II trial of combination chemotherapy and irradiation in nonsmall cell lung cancer, Radiation Therapy Oncology Group 88-04. Am J Clin Oncol. 15:1992;163-167.
7. Sause W.T., Scott C., Taylor S., et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Group (ECOG) 4588 Preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer . J Natl Cancer Inst. 87:1995;198-205.
8. Byhardt R.W., Scott C.B., Ettinger D.S., Curran W.J., Doggett R.L.S., Coughlin C., Scarantino C., Rotman M., Emami B. Concurrent hyperfractionated irradiation and chemotherapy for unresectable non-small cell lung cancer. Results of Radiation Therapy Oncology Group (RTOG) 90-15. (Abst.) Lung Cancer. 1994;188.
9. Lee J.S., Scott C., Komaki R., Fossella F., Dundas G.S., McDonald S., Curran W.J., Byhardt R.W. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable nonsmall cell lung cancer Radiation Therapy Oncology Group protocol 91-06 . (Abst 1222) J Clin Oncol. 14:1996;1055-1064.
10. Komaki R., Scott C., Ettinger D., Lee J.S., Fossella F.V., Curran W., Evans R.F., Rubin P., Byhardt R.W. Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer Radiation Therapy Oncology Group (RTOG) 92-04 . Int J Radiat Oncol Biol Phys. 38:1997;149-155.
11. Kiricuta J.C., Mueller G., Stiess J., Bohndorf W. The lymphatic pathways of non-small cell lung cancer and their implication in curative irradiation. Lung Cancer. 11:1994;71-82.
12. Lanzotti V.J., Thomas D.R., Boyle L.E., Smith T.L., Gehan E.A., Samuels M.L. Survival with inoperable lung cancer An integration of prognostic variables based on simple clinical criteria . Cancer. 39:1977;303-313.
13. Emami B, Graham MV. Lung. Book Section Lung. In: Perez CA, Brady LW, editors. Principles and practice of radiation oncology. Philadelphia: Lippincott-Raven; 1998. p. 1181-1220.
14. Komaki R., Cox J.D., Hartz A.J., et al. Characteristics of long-term survivors after treatment for inoperable carcinoma of the lung. Am J Clin Oncol. 8:1985;362-370.
15. Bonomi P., Kim K., Kugler J., Johnson D. Comparison of survival for stage IIIB vs. stage IV non-small cell lung cancer (NSCLC) patients treated with etoposide-cisplatin vs. Taxol-cisplatin: An Eastern Cooperative Group (ECOG) trial. (Abst. #1631) Proc Am Soc Clin Oncol, Denver. 1997;455.
16. Albain K.S., Rusch V.W., Crowley J.J., et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA(N2) and IIIB non-small cell lung cancer Mature results of Southwest Oncology Group phase II study 8805 . J Clin Oncol. 13:1995;1880-1892.
17. Kubota K., Furuse K., Kawahara M., Kodama N., Yamamoto M., Ogawara M., Negoro S., Masuda N., Takada M., Matsui K., Takifuji N., Kudoh S., Kusunoki Y., Fukuoka M. Role of radiotherapy in combined modality treatment of locally advanced non-small cell lung cancer. J Clin Oncol. 12:1994;1547-1552.